159 related articles for article (PubMed ID: 1802922)
1. The relative contribution of androgens and insulin in determining abdominal body fat distribution in premenopausal women.
Pasquali R; Casimirri F; Balestra V; Flamia R; Melchionda N; Fabbri R; Barbara L
J Endocrinol Invest; 1991 Nov; 14(10):839-46. PubMed ID: 1802922
[TBL] [Abstract][Full Text] [Related]
2. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.
Dunaif A; Graf M; Mandeli J; Laumas V; Dobrjansky A
J Clin Endocrinol Metab; 1987 Sep; 65(3):499-507. PubMed ID: 3305551
[TBL] [Abstract][Full Text] [Related]
3. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
4. Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism.
Pasquali R; Casimirri F; Cantobelli S; Labate AM; Venturoli S; Paradisi R; Zannarini L
Horm Res; 1993; 39(5-6):179-87. PubMed ID: 8314200
[TBL] [Abstract][Full Text] [Related]
5. Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels.
Vicennati V; Gambineri A; Calzoni F; Casimirri F; Macor C; Vettor R; Pasquali R
Metabolism; 1998 Aug; 47(8):988-92. PubMed ID: 9711997
[TBL] [Abstract][Full Text] [Related]
6. Body fat composition and distribution in women with polycystic ovary syndrome.
Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
[TBL] [Abstract][Full Text] [Related]
7. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
Apter D; Bützow T; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
[TBL] [Abstract][Full Text] [Related]
8. Insulin as a factor of increased androgen production in women with obesity and polycystic ovaries.
Pasquali R; Antenucci D; Casimirri F; Venturoli S; Paradisi R; Fabbri R; Melchionda N; Barbara L
J Endocrinol Invest; 1987 Dec; 10(6):575-9. PubMed ID: 3326891
[TBL] [Abstract][Full Text] [Related]
9. Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome.
Pasquali R; Casimirri F; Venturoli S; Antonio M; Morselli L; Reho S; Pezzoli A; Paradisi R
Metabolism; 1994 Jun; 43(6):706-13. PubMed ID: 8201958
[TBL] [Abstract][Full Text] [Related]
10. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
[TBL] [Abstract][Full Text] [Related]
11. Body fat distribution in pre- and post-menopausal women: metabolic and anthropometric variables and their inter-relationships.
Zamboni M; Armellini F; Milani MP; De Marchi M; Todesco T; Robbi R; Bergamo-Andreis IA; Bosello O
Int J Obes Relat Metab Disord; 1992 Jul; 16(7):495-504. PubMed ID: 1323546
[TBL] [Abstract][Full Text] [Related]
12. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss.
Pasquali R; Antenucci D; Casimirri F; Venturoli S; Paradisi R; Fabbri R; Balestra V; Melchionda N; Barbara L
J Clin Endocrinol Metab; 1989 Jan; 68(1):173-9. PubMed ID: 2642485
[TBL] [Abstract][Full Text] [Related]
13. The role of the opioid peptides in the development of hyperinsulinemia in obese women with abdominal body fat distribution.
Pasquali R; Cantobelli S; Casimirri F; Bortoluzzi L; Boschi S; Capelli M; Melchionda N; Barbara L
Metabolism; 1992 Jul; 41(7):763-7. PubMed ID: 1619995
[TBL] [Abstract][Full Text] [Related]
14. Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients.
Maccario M; Ramunni J; Oleandri SE; Procopio M; Grottoli S; Rossetto R; Savio P; Aimaretti G; Camanni F; Ghigo E
Int J Obes Relat Metab Disord; 1999 Jun; 23(6):612-8. PubMed ID: 10411234
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovary syndrome: obesity, insulin resistance, hyperandrogenism.
Lo Dico G; Alongi G; Savatteri L; Rini GB; Mascellino MR; Di Fede G; Rizzo G
Acta Eur Fertil; 1989; 20(5):309-13. PubMed ID: 2700062
[TBL] [Abstract][Full Text] [Related]
16. Body composition, glucose metabolism markers and serum androgens - association in women with polycystic ovary syndrome.
Kozakowski J; Zgliczyński W
Endokrynol Pol; 2013; 64(2):94-100. PubMed ID: 23653271
[TBL] [Abstract][Full Text] [Related]
17. Secretion of major adrenal androgens following ACTH administration in obese women with different body fat distribution.
Vicennati V; Calzoni F; Gambineri A; Gagliardi L; Morselli Labate AM; Casimirri F; Pasquali R
Horm Metab Res; 1998 Mar; 30(3):133-6. PubMed ID: 9566854
[TBL] [Abstract][Full Text] [Related]
18. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
Van Gaal L
Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
[TBL] [Abstract][Full Text] [Related]
19. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
Romualdi D; De Cicco S; Tagliaferri V; Proto C; Lanzone A; Guido M
J Clin Endocrinol Metab; 2011 May; 96(5):E821-4. PubMed ID: 21307134
[TBL] [Abstract][Full Text] [Related]
20. The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women.
Graf MJ; Richards CJ; Brown V; Meissner L; Dunaif A
Clin Endocrinol (Oxf); 1990 Jul; 33(1):119-31. PubMed ID: 2205423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
